Avadel Pharmaceuticals PLC (AVDL): Rega marang dodolan

The premium positioning of Lumryz provides Avadel Pharmaceuticals (AVDL) with strong pricing power. The current P/S multiple reflects market expectations, with the value holding at 8.50. The business relies on insurance reimbursements for its innovative narcolepsy therapy. High macro-resilience and a lack of seasonality make the company's revenue independent of economic crises.

Kapitalisasi marang pendapatan: avadel.com (AVDL) kanggo 13.08.2023 - 28.02.2026

Rincian analitis perusahaan Avadel Pharma (AVDL)

- rega saham lan konsensus proyeksi valuasi:

Bagan owah-owahan rega avadel.com|AVDL - Bagan rega target

- data kapitalisasi bursa:

Nilai pasar Avadel Pharma|AVDL - Nilai Perusahaan

- data nilai buku modal saham:

Nilai Buku saben Saham Avadel Pharmaceuticals|AVDL - Aset Bersih Perusahaan|Rasio Nilai Pasar marang Nilai Buku avadel.com|AVDL - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

Total Utang marang Modal Avadel Pharmaceuticals|AVDL - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang modal Avadel Corp|AVDL - Gunggung utang perusahaan|Utang-utang marang nilai buku Avadel Pharma|AVDL - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Avadel Pharmaceuticals|Rasio jangkoan perantara avadel.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

AVDL - Bathi resik perusahaan|Bathi forward Avadel Pharmaceuticals|AVDL - Pangali P/E|Pangali mangsa ngarep rega marang bathi Avadel Pharmaceuticals PLC|AVDL - Pangali PEG|Pangali EV/EBITDA Avadel Pharma|AVDL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben saham sajroning taun lumaku Avadel Pharmaceuticals|AVDL - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan avadel.com|AVDL - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Avadel Pharmaceuticals

- indikator pendapatan dodolan lan penghasilan bisnis:

AVDL - Pendapatan lan volume dodolan|Volume dodolan mangsa ngarep perusahaan avadel.com|AVDL - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Avadel Pharma

Analisis umum perusahaan:AVDL - avadel.com

Identifying fundamentally resilient assets requires analyzing the ratio of a business's market value to its annual revenue. This price-to-sales multiple determines the price of each unit of sales, which for Avadel Pharmaceuticals (AVDL) confirms a premium valuation due to the exclusivity of its narcolepsy drug patent and guaranteed demand, reflecting the real-time value dynamics shown in this chart.

Pesaing Avadel Pharmaceuticals

ALKS (alkermes.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan atai Life Sciences ATAI|GH Research plc (GHRS) - Rega marang dodolan|MindMed Inc. - Multiplikator P/S|CMPS - Multiplikator P/S|LBRX (LB Pharmaceuticals Inc) - Kapitalisasi marang pendapatan|DRUG (brightmindsbio.com) - Rasio rega marang pendapatan|VNDA (Vanda Pharmaceuticals Inc.) - Multiplikator P/S|Multiplikator P/S Cybin Corp|Multiplikator P/S ANRO|NRx Pharmaceuticals, Inc - Rasio kapitalisasi marang pendapatan|Multiplikator P/S CING (Cingulate)|Silo Pharma Inc. (SILO) - Rega marang dodolan|CPHI - Rasio rega marang pendapatan|CMND: Rasio rega marang pendapatan|PBM (Psyence Biomedical Limited) - Kapitalisasi marang pendapatan|SciSparc Corp - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Seelos Therapeutics|Virpax - Rasio rega marang dodolan|Multiplikator P/S KRTX